The journal Science has chosen the HPTN 052 clinical trial, an international HIV prevention trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, as the 2011 Breakthrough of the Year. The study found that if HIV-infected heterosexual individuals begin taking antiretroviral medicines when their immune systems are relatively healthy as opposed to delaying therapy until the disease has advanced, they are 96 percent less likely to transmit the virus to their uninfected partners. Findings from the trial, first announced in May, were published in the New England Journal of Medicine in August.
“Yeah, but good luck getting it peer reviewed.”
(via The New Yorker)
Medicine is not only a science; it is also an art. It does not consist of compounding pills and plasters; it deals with the very processes of life, which must be understood before they may be guided.

Medicare outpatient claims for 2008 are showing that thousands of Medicare patients received unnecessary double CT scans that year. The practice not only costs the Medicare program millions of dollars, but exposes patients to potentially dangerous doses of radiation.
Atropine Sulphate: Atropine is a classic parasympatholytic drug that reduces vagal tone, enhances the rate of discharge of the sino-atrial node, and facilitates atrioventricular conduction. Instead of inducing tachycardia, the drug reduces the likelihood of ventricular fibrillation, triggered by myocardial hypoperfusion, which is associated with extreme bradycardia and heart blocks (but not in complete atrioventricular block where isoprenaline is definitely indicated and the former has no place). Atropine, therefore, has essentially no place during CPR except possibly in refractory asystole. When the spontaneous circulation has resumed and the heart rate has dropped to or below 50 beats/min or when there is bradycardia with premature ventricular complexes or hypotension, then atropine is indicated. Atropine may also be beneficial in the presence of atrioventricular block at the nodal level.
(source: http://www.angelfire.com/mt/CPR/ART6.html)

A trial that had originally been planned to run until 2015, testing whether treating an HIV-infected person with antiretroviral drugs could prevent that person from passing the disease along to his partner, stopped on thursday. Because it was so successful.

It seems, with the way technology has been moving, everything in the future will detect cancer. The latest to promise this ability is a microscope developed by the ever-innovative Fraunhofer Institute, capable of imaging a suspicious area of skin for melanomas.
The latest issue of WSMedicalReview is available now, along with all back issues! Click Here or on the poster to download your free copies now!

A pill that gives men with advanced prostate cancer an extra four months of life has come a step closer to being approved for use in Britain.

Scientists, already adept at using magnets to screw with the brain’s ability to generate speech, are now sending direct current into people’s brain matter to help them master video games.

The Nintendo 3DS, once slammed as an eye-destroying device, is now being thought of as a tool for diagnosing eye disorders. According to Digital Trends, optometrists feel this could be a useful tool for early warning signs.

You know the UV-ink rubber stamps at night clubs? Well, a novel silver nanotech variant of the idea could actually help heal your skin wounds more quickly.
Three new oral blood-thinning drugs nearing approval by the Food and...
the truth about me is that I genuinely believe that nothing is as bad as it seems. the truth about me is that I feel and think things I’m...
Temporarily together (via raw_reflex)
I like the cool “http” board. Looks like an internet suite!